verified SJR 0,271 · Q2 • database Scopus / SJR indexed

Germany · Walter de Gruyter GmbH

workspace_premium Q2 — Pharmacology (medical) lock Subscription

Drug Metabolism and Personalized Therapy

Drug Metabolism and Personalized Therapy is a journal indexed in SJR in Pharmacology (medical) and Pharmacology, Toxicology and Pharmaceutics (miscellaneous) with an H index of 40. It has an SJR impact factor of 0,271 and it has a best quartile of Q2. It has an SJR impact factor of 0,271.

ISSN: 2363-8907

Publisher: Walter de Gruyter GmbH

Category: Pharmacology (medical)

Indexation: verifiedScopus / SJR

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,271 Q2

H-index 40

Acceptance rate pie_chart

34%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR

SJR Impact

0,271

H-index

Docs (year)

Docs 3y

136

Total refs

1280

Cites 3y

135

Citable 3y

127

Cites/Doc 2y

1.03

Ref/Doc

44.14

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Clinical implementation of pharmacogenetics

Which cytochrome P450 metabolizes phenazepam? Step by step in silico, in vitro, and in vivo studies

Effects of CYP2C19*17 polymorphisms on the efficacy and safety of bromodigyrochlorophenylbenzodiazepine in patients with anxiety disorder and comorbid alcohol use disorder

Effect of the African-specific promoter polymorphisms on the SLC22A2 gene expression levels

Effect of rifampin on the pharmacokinetics of bosutinib, a dual Src/Abl tyrosine kinase inhibitor, when administered concomitantly to healthy subjects

Effect of baseline renal and hepatic function on the incidence of adverse drug events: the Japan Adverse Drug Events study

Early disease relapse in a patient with colorectal cancer who harbors genetic variants of DPYD, TYMS, MTHFR and DHFR after treatment with 5-fluorouracil-based chemotherapy

Distribution of CYP2D6 genotypes in the Indian population -preliminary report

CYP2D6 variability in populations from Venezuela

CYP2D6 in Amerindians from Southern Mexico: low variability and higher frequency of functional alleles

Correlation between plasma concentrations of tramadol and its metabolites and the incidence of seizure in tramadol-intoxicated patients

Complex method for calculating total serum calcium concentration

SHOW MORE ARTICLES

Clinical prospects of IGF-signaling system components study in ovarian cancer patients

8th Santorini Conference: Systems medicine and personalized health and therapy, Santorini, Greece, 3-5 October 2016

Clinical drug-drug interactions: focus on venlafaxine

Chloral hydrate, through biotransformation to dichloroacetate, inhibits maleylacetoacetate isomerase and tyrosine catabolism in humans

Carboxylesterase 1A2 encoding gene with increased transcription and potential rapid drug metabolism in Asian populations

Association study of DRD2 A2/A1, DRD3 Ser9Gly, DbetaH -1021C>T, OPRM1 A118G and GRIK1 rs2832407C>A polymorphisms with alcohol dependence

Association of ABCB1, ABCC5 and xanthine oxidase genetic polymorphisms with methotrexate adverse reactions in Mexican pediatric patients with ALL

Assessment of cytochrome P450 inhibition and induction potential of lupeol and betulin in rat liver microsomes

Assessment of CYP2D6 re-activation after inhibitory effect of MDMA using tramadol as a probe

Application of the extended clearance concept classification system (ECCCS) to predict the victim drug-drug interaction potential of statins

An update on HLA alleles associated with adverse drug reactions

Altered pharmacokinetics of rosiglitazone in a mouse model of non-alcoholic fatty liver disease

FAQs

Drug Metabolism and Personalized Therapy has an SJR of 0,271 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Drug Metabolism and Personalized Therapy is 34%.

Drug Metabolism and Personalized Therapy

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Drug Metabolism and Personalized Therapy?

What is the APC / publication cost?

What is the acceptance rate?